Drugs that target metal beta-amyloid interactions can effect Alzheimer's disease. Commentary: Metal-protein attenuation with iodochlorohydroxyquine (clioquinol) targeting beta-amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial.
College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.
David R P
DR
Guay